Project Grant R01HD114678
Award Date
9/3/24
Completion Date
8/31/29
Dollars Obligated
$398K
Federal Agency
National Institute of Child Health and Human Development
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
This Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund two parallel randomized clinical trials to implement and investigate the efficacy and safety of a methadone-based standardized Enhanced Recovery After Surgery (ERAS) protocol, as well as develop personalized ERAS protocols including precision methadone and oxycodone dosing, for the opioid-sparing management of...
This federal Cooperative Agreement award of $6,842,922 was issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award will fund the "Optimizing Pain Treatment in Children on Mechanical Ventilation (OPTICOM)" study, a 5-year, multi-site clinical trial to evaluate the effectiveness of non-opioid adjuvant therapies (acetaminophen and/or ketorolac) in reducing acute pain and opioid exposure in...
This $779,969 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to improve perioperative care for patients with opioid use disorder. The key objectives are to: Prospectively capture patient-reported pain and opioid use data among individuals with opioid use disorder undergoing common surgical procedures, and develop evidence-based prescribing guidelines. Qualitatively assess the perioperative experiences...
This $701,959 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to improve perioperative care for patients with opioid tolerance in the United States. The key objectives are to: Prospectively capture patient-reported opioid use and pain outcomes among opioid-tolerant individuals undergoing common surgical procedures, and develop a clinical care pathway to optimize outcomes across a network of hospitals...
This Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $6,806,538 to conduct an 8-site randomized clinical trial comparing intravenous sub-dissociative ketamine to intravenous morphine for treating acute pain in 1,010 children aged 6-17 presenting to emergency departments. The goal is to determine if ketamine is non-inferior to morphine for reducing pain intensity and...
The National Institute on Drug Abuse (NIDA) awarded The Children's Hospital Corporation, doing business as Boston Children's Hospital, a $267,000 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to develop tamper- and diversion-proof injectable depot formulations of opioids. The goal is to create covalently bonded opioid-polymer depots that can be subcutaneously injected and release opioids only when exposed to light, allowing patients to control the timing and intensity of...
This $1,499,606 Project Grant award was issued by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The primary awardee, Dartmouth-Hitchcock Clinic, will lead a multidisciplinary research project to characterize health outcomes and disparities in children born to parents with opioid use disorder, as well as identify protective health system factors. Key objectives include: 1) examining variation in diagnosis rates of neonatal opioid...
This federal Project Grant award of $179,919.00 from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will fund a study to evaluate the effectiveness of adjuvant adenoidectomy in the surgical management of otitis media. The primary awardee is The Children's Hospital of Philadelphia (CHOP), which will lead a consortium of pediatric otolaryngologists to carry out the study's aims....
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a non-opioid therapeutic to treat surgical pain. The $427,187 award will fund research to create a peptidomimetic that blocks the interaction of the NF-κB Essential Modulator (NEMO) protein with its binding partner IKKβ. This approach seeks to limit inflammation and pain associated with surgical injury without...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $295,906 to Addinex Technologies, Inc. to integrate and assess a closed-loop medication management system for opioid pain management in ambulatory patients with extremity fractures being discharged from the emergency department. The project aims to adapt Addinex's existing medication dispensing platform to work within a hospital pharmacy setting,...